My watch list
my.bionity.com  
Login  

Endobronchial valve



 

The endobronchial valve is a medical device researched and developed in Russia, used in treatment of tuberculosis and its complications. It is a one-way valve designerd to be installed in a bronchus. It causes hypoventilation of the affected segment of a lung and preserves the drainage function of the blocked bronchus and the tissue-destruction cavity. The valve lets air and sputum and other bronchial secretion go out of the lung during abrupt expiration and coughing, but lets nothing back in during inspiration.[1]

The endobronchial valve has these features:

  • minimally invasive – no surgical incision;
  • procedure of installation of the valve lasts about five minutes;
  • intended to reduce acute hyperinflation;
  • flexible – adapts to the variable size and shape of the airway;
  • ability to “stage” procedure and treat conservatively;
  • reversible – valves are designed to be removable post implantation;
  • increased ability to carry out daily activities;
  • improved exercise tolerance;
  • increased ventilation to healthier portions of the lung.

Phthisiologists have used one-way endobronchial valves since 1999 in treatment of multi-drug resistant tuberculosis (MDR TB), extensively drug resistant tuberculosis (XDR TB) and its complications. In the U.S. they have been used in the treatment of emphysema patients.[2][3]

References

  1. ^ Michael J. Simoff, Daniel H. Sterman, Armin Ernst (2006). Thoracic Endoscopy: advances in interventional pulmonology . Blackwell Publishing, 191. ISBN 1405122048. 
  2. ^ Seshu Pisipati (July 29, 2004), , The Daily Iowan,
  3. ^ , Channel 3000, March 25, 2004,
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Endobronchial_valve". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE